Shared genetic-neuroimaging and genetic-clinical functional pathways included well-known PD-associated molecular functions (e.g., angiogenesis, modulation of dopaminergic cell activity) and more recently proposed PD mechanisms (e.g., gonadotropin-releasing hormone receptor, immune markers). The gene discussed is GNRHR; the disease is Parkinson disease.